Commonwealth Equity Services’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$459K Buy
4,201
+27
+0.6% +$2.57K ﹤0.01% 3281
2025
Q4
$338K Sell
4,174
-124
-3% -$10.7K ﹤0.01% 3548
2025
Q3
$376K Sell
4,298
-3,486
-45% -$311K ﹤0.01% 3428
2025
Q2
$647K Buy
7,784
+3
+0% +$251 ﹤0.01% 2948
2025
Q1
$653K Sell
7,781
-13
-0.2% -$1.21K ﹤0.01% 2822
2024
Q4
$718K Sell
7,794
-2,171
-22% -$209K ﹤0.01% 2674
2024
Q3
$926K Sell
9,965
-490
-5% -$42.5K ﹤0.01% 2413
2024
Q2
$860K Sell
10,455
-557
-5% -$40.9K ﹤0.01% 2395
2024
Q1
$731K Sell
11,012
-17
-0.2% -$1.05K ﹤0.01% 2485
2023
Q4
$626K Buy
11,029
+7
+0.1% +$367 ﹤0.01% 2527
2023
Q3
$600K Buy
11,022
+64
+0.6% +$3.79K ﹤0.01% 2439
2023
Q2
$737K Buy
10,958
+66
+0.6% +$4.03K ﹤0.01% 2327
2023
Q1
$560 Buy
10,892
+25
+0.2% +$1.21K ﹤0.01% 2457
2022
Q4
$500K Buy
10,867
+84
+0.8% +$3.93K ﹤0.01% 2471
2022
Q3
$546K Buy
10,783
+19
+0.2% +$949 ﹤0.01% 2334
2022
Q2
$490K Sell
10,764
-189
-2% -$8.45K ﹤0.01% 2415
2022
Q1
$509K Sell
10,953
-505
-4% -$22.6K ﹤0.01% 2506
2021
Q4
$575K Sell
11,458
-136
-1% -$7.03K ﹤0.01% 2410
2021
Q3
$615K Buy
11,594
+1,603
+16% +$90.3K ﹤0.01% 2314
2021
Q2
$609K Buy
9,991
+604
+6% +$32.1K ﹤0.01% 2315
2021
Q1
$457K Sell
9,387
-345
-4% -$16.2K ﹤0.01% 2402
2020
Q4
$394K Buy
9,732
+836
+9% +$29.9K ﹤0.01% 2325
2020
Q3
$289K Sell
8,896
-2,395
-21% -$71.9K ﹤0.01% 2387
2020
Q2
$298K Sell
11,291
-383
-3% -$10K ﹤0.01% 2283
2020
Q1
$290K Sell
11,674
-85
-0.7% -$2.63K ﹤0.01% 2096
2019
Q4
$422K Buy
11,759
+11
+0.1% +$380 ﹤0.01% 2043
2019
Q3
$401K Sell
11,748
-397
-3% -$12.7K ﹤0.01% 1991
2019
Q2
$339K Buy
12,145
+31
+0.3% +$861 ﹤0.01% 2104
2019
Q1
$375K Buy
12,114
+1,141
+10% +$30.4K ﹤0.01% 1979
2018
Q4
$259K Buy
10,973
+2,092
+24% +$57.1K ﹤0.01% 2133
2018
Q3
$344K Buy
8,881
+9
+0.1% +$324 ﹤0.01% 2057
2018
Q2
$297K Buy
8,872
+18
+0.2% +$640 ﹤0.01% 2132
2018
Q1
$320K Buy
8,854
+425
+5% +$14.7K ﹤0.01% 2019
2017
Q4
$268K Buy
8,429
+7
+0.1% +$240 ﹤0.01% 2127
2017
Q3
$315K Sell
8,422
-195
-2% -$6.64K ﹤0.01% 1946
2017
Q2
$269K Buy
8,617
+18
+0.2% +$520 ﹤0.01% 1995
2017
Q1
$212K Buy
+8,599
New +$202K ﹤0.01% 2103

Other funds holding LMAT

Commonwealth Equity Services's LMAT Position: Q1 2026 in Review

Commonwealth Equity Services increased its LeMaitre Vascular (LMAT) stake by 0.65% in Q1 2026, buying an estimated $2.57K and bringing the position to 4,201 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #3281.

Commonwealth Equity Services first reported a position in LMAT in Q1 2017 and has held it in 37 quarters since. The position peaked at $926K in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Commonwealth Equity Services held 4,201 shares of LeMaitre Vascular worth $459K as of Q1 2026.
  • Commonwealth Equity Services bought 27 LeMaitre Vascular shares in Q1 2026, an estimated $2.57K.
  • LeMaitre Vascular made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3281 holding.
  • Commonwealth Equity Services first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 37 quarters since.
  • Commonwealth Equity Services's LeMaitre Vascular position peaked at $926K in Q3 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.